The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes.
Saved in:
| Title: | The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes. |
|---|---|
| Authors: | Denorme F; Program in Molecular Medicine and.; Department of Neurology, Division of Vascular Neurology, University of Utah, Salt Lake City, Utah, USA., Armstrong ND; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Stoller ML; Program in Molecular Medicine and., Portier I; Program in Molecular Medicine and., Tugolukova EA; Program in Molecular Medicine and., Tanner RM; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Montenont E; Program in Molecular Medicine and., Bhatlekar S; Program in Molecular Medicine and., Cody M; Program in Molecular Medicine and., Rustad JL; Program in Molecular Medicine and., Ajanel A; Program in Molecular Medicine and., Tolley ND; Program in Molecular Medicine and., Murray DC; Program in Molecular Medicine and., Boyle JL; Bioinformatics Shared Resource, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Nieman MT; Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio, USA., McKenzie SE; Department of Medicine, The Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Yost CC; Program in Molecular Medicine and.; Department of Pediatrics, Division of Neonatology, University of Utah, Salt Lake City, Utah, USA., Lange LA; Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Cushman M; Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA., Irvin MR; Department of Neurology, Division of Vascular Neurology, University of Utah, Salt Lake City, Utah, USA., Bray PF; Program in Molecular Medicine and.; Department of Internal Medicine, Division of Hematology and Hematologic Malignancies, and., Campbell RA; Program in Molecular Medicine and.; Department of Internal Medicine, Division of Hematology and Hematologic Malignancies, and.; Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, Utah, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2023 Sep 15; Vol. 133 (18). Date of Electronic Publication: 2023 Sep 15. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37471144 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Denorme+F%22">Denorme F</searchLink>; Program in Molecular Medicine and.; Department of Neurology, Division of Vascular Neurology, University of Utah, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+ND%22">Armstrong ND</searchLink>; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Stoller+ML%22">Stoller ML</searchLink>; Program in Molecular Medicine and.<br /><searchLink fieldCode="AU" term="%22Portier+I%22">Portier I</searchLink>; Program in Molecular Medicine and.<br /><searchLink fieldCode="AU" term="%22Tugolukova+EA%22">Tugolukova EA</searchLink>; Program in Molecular Medicine and.<br /><searchLink fieldCode="AU" term="%22Tanner+RM%22">Tanner RM</searchLink>; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Montenont+E%22">Montenont E</searchLink>; Program in Molecular Medicine and.<br /><searchLink fieldCode="AU" term="%22Bhatlekar+S%22">Bhatlekar S</searchLink>; Program in Molecular Medicine and.<br /><searchLink fieldCode="AU" term="%22Cody+M%22">Cody M</searchLink>; Program in Molecular Medicine and.<br /><searchLink fieldCode="AU" term="%22Rustad+JL%22">Rustad JL</searchLink>; Program in Molecular Medicine and.<br /><searchLink fieldCode="AU" term="%22Ajanel+A%22">Ajanel A</searchLink>; Program in Molecular Medicine and.<br /><searchLink fieldCode="AU" term="%22Tolley+ND%22">Tolley ND</searchLink>; Program in Molecular Medicine and.<br /><searchLink fieldCode="AU" term="%22Murray+DC%22">Murray DC</searchLink>; Program in Molecular Medicine and.<br /><searchLink fieldCode="AU" term="%22Boyle+JL%22">Boyle JL</searchLink>; Bioinformatics Shared Resource, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Nieman+MT%22">Nieman MT</searchLink>; Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22McKenzie+SE%22">McKenzie SE</searchLink>; Department of Medicine, The Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Yost+CC%22">Yost CC</searchLink>; Program in Molecular Medicine and.; Department of Pediatrics, Division of Neonatology, University of Utah, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Lange+LA%22">Lange LA</searchLink>; Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Cushman+M%22">Cushman M</searchLink>; Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.<br /><searchLink fieldCode="AU" term="%22Irvin+MR%22">Irvin MR</searchLink>; Department of Neurology, Division of Vascular Neurology, University of Utah, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Bray+PF%22">Bray PF</searchLink>; Program in Molecular Medicine and.; Department of Internal Medicine, Division of Hematology and Hematologic Malignancies, and.<br /><searchLink fieldCode="AU" term="%22Campbell+RA%22">Campbell RA</searchLink>; Program in Molecular Medicine and.; Department of Internal Medicine, Division of Hematology and Hematologic Malignancies, and.; Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, Utah, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2023 Sep 15; Vol. 133 (18). <i>Date of Electronic Publication: </i>2023 Sep 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37471144 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI169608 Languages: – Code: eng Text: English Titles: – TitleFull: The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Denorme F – PersonEntity: Name: NameFull: Armstrong ND – PersonEntity: Name: NameFull: Stoller ML – PersonEntity: Name: NameFull: Portier I – PersonEntity: Name: NameFull: Tugolukova EA – PersonEntity: Name: NameFull: Tanner RM – PersonEntity: Name: NameFull: Montenont E – PersonEntity: Name: NameFull: Bhatlekar S – PersonEntity: Name: NameFull: Cody M – PersonEntity: Name: NameFull: Rustad JL – PersonEntity: Name: NameFull: Ajanel A – PersonEntity: Name: NameFull: Tolley ND – PersonEntity: Name: NameFull: Murray DC – PersonEntity: Name: NameFull: Boyle JL – PersonEntity: Name: NameFull: Nieman MT – PersonEntity: Name: NameFull: McKenzie SE – PersonEntity: Name: NameFull: Yost CC – PersonEntity: Name: NameFull: Lange LA – PersonEntity: Name: NameFull: Cushman M – PersonEntity: Name: NameFull: Irvin MR – PersonEntity: Name: NameFull: Bray PF – PersonEntity: Name: NameFull: Campbell RA IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: 2023 Sep 15 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 133 – Type: issue Value: 18 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |